Enzymatica AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

22.06.21	Enzymatica appoints new Director of Quality Assurance and Communication Manager (PR Newswire)
05.04.19	Enzymatica AB:Notice of annual general meeting 2019 in Enzymatica AB (publ) (GlobeNewswire)
01.04.19	Enzymatica AB: - Publication of the annual report 2018 (GlobeNewswire)
19.02.19	Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany (GlobeNewswire)
30.01.19	Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme (GlobeNewswire)
25.01.19	Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims (GlobeNewswire)
10.12.18	Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled (GlobeNewswire)
02.12.18	Enzymatica AB: Enzymatica raises SEK 98.7 million in completed share issue (GlobeNewswire)
12.11.18	Enzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders published (GlobeNewswire)
05.11.18	Enzymatica AB: Bulletin from Extraordinary General Meeting in Enzymatica AB (publ) (GlobeNewswire)
02.11.18	Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent (GlobeNewswire)
31.10.18	Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany (GlobeNewswire)
18.10.18	Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ) (GlobeNewswire)
18.10.18	Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million (GlobeNewswire)
18.10.18	Enzymatica AB: Enzymatica signs agreement for the Japanese market (GlobeNewswire)
01.10.18	Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold symptom scales (GlobeNewswire)
29.08.18	Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany (GlobeNewswire)
31.07.18	Enzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa (GlobeNewswire)
17.07.18	Enzymatica AB: Lower sales in Q2 but 31% increase for the first half of the year (GlobeNewswire)
16.07.18	Enzymatica AB: Court ruling put restrictions on marketing of Enzymatica's cold spray in Germany (GlobeNewswire)
07.06.18	Enzymatica AB: Enzymatica secures funding for operations (GlobeNewswire)
22.05.18	Enzymatica AB: Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus (GlobeNewswire)
26.04.18	Enzymatica AB: Continued growth during the first quarter (GlobeNewswire)
11.04.18	Enzymatica AB: New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus (GlobeNewswire)
09.04.18	Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness (GlobeNewswire)
28.03.18	Enzymatica AB: Enzymatica - publication of the annual report 2017 (GlobeNewswire)
21.03.18	Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ) (GlobeNewswire)
14.02.18	Enzymatica AB: Strong growth and international breakthrough in 2017 (GlobeNewswire)
29.11.17	Enzymatica AB: Enzymatica's Nomination Committee for the Annual General Meeting 2018 appointed (GlobeNewswire)
14.11.17	Enzymatica AB: Enzymatica announces a study showing the ability of ColdZyme to deactivate major common cold viruses (GlobeNewswire)
09.11.17	Enzymatica AB: ColdZyme study - Most recommended cold product at pharmacies (GlobeNewswire)
01.11.17	Enzymatica AB: Interim report for Enzymatica AB (publ) January-September 2017 (GlobeNewswire)
25.10.17	Enzymatica AB: Bulletin from extraordinary general meeting in Enzymatica AB (publ) (GlobeNewswire)
18.10.17	Enzymatica AB: Complete article from COLDPREV I study published - strengthens documentation for ColdZyme (GlobeNewswire)
06.09.17	Enzymatica recruits Chief Financial Officer (GlobeNewswire)
20.07.17	Enzymatica AB: Continued sales growth and breakthrough order from STADA (GlobeNewswire)
18.07.17	Enzymatica recruits Chief Commercial Officer (GlobeNewswire)
14.07.17	Enzymatica recruits Chief Operating Officer (GlobeNewswire)
21.12.16	Enzymatica AB: Top-line results of new clinical trial (GlobeNewswire)
01.12.16	Enzymatica AB: NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING IN ENZYMATICA AB (publ) (GlobeNewswire)
03.11.16	Enzymatica AB: ColdZyme® sales continue to perform well (GlobeNewswire)
02.11.16	Enzymatica AB: Enzymatica signs distribution agreement with Endeavour Consumer Health (GlobeNewswire)
30.08.16	Enzymatica AB: The board of directors in Enzymatica has resolved on a directed share issue of SEK 40.3 million (GlobeNewswire)
18.07.16	Enzymatica AB: Excellent volume growth for ColdZyme® (GlobeNewswire)
25.05.16	Bulletin from the Annual General Meeting in Enzymatica AB (publ) (GlobeNewswire)
11.05.16	Enzymatica's new rights issue completed - will be provided with SEK 60 million (GlobeNewswire)
03.05.16	Enzymatica insiders plan to subscribe for SEK 16 million in new issue (GlobeNewswire)
26.04.16	Notice of annual general meeting in Enzymatica AB (publ) (GlobeNewswire)
20.04.16	Enzymatica publishes prospectus (GlobeNewswire)
20.04.16	Enzymatica - publication of the annual report 2015 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Holcim	98.54	3.01 %	K V
UBS Group	30.90	2.69 %	K V
Givaudan	4’058.00	1.20 %	K V
CieFinRichemont	183.50	0.82 %	K V
Swisscom	513.50	0.69 %	K V
Swiss Re	144.30	-0.62 %	K V
Geberit	528.40	-0.83 %	K V
Sonova Hldg	289.00	-1.03 %	K V
ABB	48.31	-1.33 %	K V
Logitech Intl	88.40	-4.70 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Enzymatica AB

Aktien Top/Flop

Meistgelesene Nachrichten